Skip to content

Iron Sucrose Versus Blood Transfusion In The Management Of Moderate Post Partum Iron Deficiency Anemia.

Intravenous Iron Sucrose Versus Blood Transfusion In The Management Of Moderate Post Partum Iron Deficiency Anemia. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104618
Enrollment
155
Registered
2026-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Iron Sucrose,Blood Transfusion: Postpartum female with moderate iron defieciency anemia selected after ramdomisation will be given either iron sucrose or blood transfusion.The level of

Sponsors

Dr Sakshi Bhojwani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consenting and willing for follow up postpartum women within the age group of 18 to 40 years.Women who delivered a single intrauterine live foetus.Women with hemodynamically stable status postpartum with haemoglobin concentration of 7 to 9.9 gm percent after 48 hours of delivery.

Exclusion criteria

Exclusion criteria: Women with haemoglobin concentration of less than 7 gm percent (severe anaemia) or more than equal to 10 gm percent (mild anaemia). Women with excessive bleeding or with hemodynamic instability. Women delivering more than or equal to twin foetuses. Women with known hypersensitivity to either iron sucrose or blood transfusion and with known history of other atopic disorders. Women with known hemoglobinopathies like sickle cell anaemia, thalassemia, G6PD deficiency or bone marrow disorders. Women with acute or chronic infections or having pre existing significant renal or hepatic dysfunction. Women unwilling to receive blood products or iron therapy.

Design outcomes

Primary

MeasureTime frame
Increase in haemoglobin concentration serum ferritin level postpartum is the primary endpoint.Timepoint: 2 and 6 weeks

Secondary

MeasureTime frame
Increase in the levels of other haematological parameters like mean corpuscular volume (MCV) , mean corpuscular haemoglobin (MCH) , mean corpuscular haemoglobin concentration (MCHC ) & reticulocyte count.Timepoint: 6 weeks

Countries

India

Contacts

Public ContactDr. Meena Jotwani

Datta Meghe Institue Of Higher Education and Research

meenakhatri619@yahoo.com8180808281

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026